De Las Salas Roxana, Díaz-Agudelo Daniela
Departamento de Enfermería, División Ciencias de la Salud, Universidad del Norte, Barranquilla, Colombia.
Biomedica. 2017 Apr 1;37(0):33-42. doi: 10.7705/biomedica.v37i1.3192.
The appearance of adverse drug reactions in neonates is an important issue due to the lack of drug safety data.
To identify the behavior of adverse drug reactions (ADR) in hospitalized neonates at two intensive care units in Barranquilla, Colombia.
We conducted a cross-sectional prospective descriptive study based on patientcentered intensive pharmacosurveillance. We followed up and monitored the appearance of ADRs for six months. We used Naranjo's algorithm to assess causality, modified Hartwig and Siegel assessment scale to establish severity and Schumock and Thornton criteria to determine ADR preventability.
We detected 123 adverse drug reactions in 78 neonates of the 284 monitored. The cumulative incidence of ADRs was 27.4% (78/284); incidence density was 30.60 ADRs per 1,000 patients/day (78/2,549). The most affected organ system was the digestive (33.6%). Systemic anti-infective drugs were the most involved pharmacological group. Most of the ADRs were mild (58.5%), 83% were classified as probable, 16.2% as possible and 0.8% as definite.
ADR incidence was high in newborns, and it increased in preterm infants (less than 38 weeks of age).
由于缺乏药物安全性数据,新生儿出现药物不良反应是一个重要问题。
确定哥伦比亚巴兰基亚两家重症监护病房住院新生儿的药物不良反应(ADR)行为。
我们基于以患者为中心的强化药物监测开展了一项横断面前瞻性描述性研究。我们对ADR的出现进行了为期六个月的随访和监测。我们使用纳伦霍算法评估因果关系,使用改良的哈特维希和西格尔评估量表确定严重程度,并使用舒莫克和桑顿标准确定ADR的可预防性。
在284名监测新生儿中的78名中,我们检测到123例药物不良反应。ADR的累积发病率为27.4%(78/284);发病密度为每1000患者/天30.60例ADR(78/2549)。受影响最严重的器官系统是消化系统(33.6%)。全身抗感染药物是涉及最多的药物类别。大多数ADR为轻度(58.5%),83%被分类为很可能,16.2%为可能,0.8%为肯定。
新生儿中ADR发病率较高,且在早产儿(小于38周龄)中有所增加。